Загрузка...

Clinical Validity and Utility of Tumor-Infiltrating Lymphocytes in Routine Clinical Practice for Breast Cancer Patients: Current and Future Directions

The interest in tumor-infiltrating lymphocytes (TILs) as a prognostic biomarker in breast cancer has grown in recent years. Biomarkers must undergo comprehensive evaluation in terms of analytical validity, clinical validity and clinical utility before they can be accepted as part of clinical practic...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Front Oncol
Главные авторы: Wein, Lironne, Savas, Peter, Luen, Stephen J., Virassamy, Balaji, Salgado, Roberto, Loi, Sherene
Формат: Artigo
Язык:Inglês
Опубликовано: Frontiers Media S.A. 2017
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5540942/
https://ncbi.nlm.nih.gov/pubmed/28824872
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2017.00156
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!